Neurofibromatosis Type 1 in Genetic Counseling Practice: Recommendations of the National Society of Genetic Counselors
Authors:Heather B. Radtke, Children’s Hospital of Wisconsin, Genetics Center, MS 716, 9000 W. Wisconsin Avenue, Milwaukee, WI 53201, USA
Courtney D. Sebold, Division of Genetics and Metabolic Disorders, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
Caroline Allison, Division of Genetics, Children’s Hospital Boston, Boston, MA, USA
Joy Larsen Haidle, Humphrey Cancer Center, North Memorial Medical Center, Robbinsdale, MN, USA
Gretchen Schneider, Harvard Medical School-Partners HealthCare Center for Genetics and Genomics, Boston, MA, USA
[Both Heather B. Radtke and Courtney D. Sebold contributed equally to this document]
Published in Journal of Genetic Counseling (Vol. 16, No. 4, pp. 387-407, August 2007).
The objective of this document is to provide recommendations for the genetic counseling of patients and families undergoing evaluation for neurofibromatosis type 1 (NF1) or who have received a diagnosis of NF1. These recommendations are the opinions of a multi-center working group of genetic counselors with expertise in the care of individuals with NF1. These recommendations are based on the committee’s clinical experiences, a review of pertinent English language medical articles, and reports of expert committees. These recommendations are not intended to dictate an exclusive course of management, nor does the use of such recommendations guarantee a particular outcome. These recommendations do not displace a health care provider’s professional judgment based on the clinical circumstances of an individual patient.
Heather B. Radtke, Children’s Hospital of Wisconsin, Genetics Center, MS 716, 9000 W. Wisconsin Avenue, Milwaukee, WI 53201, USA.
Article available online.
(C) Journal of Genetic Counseling.
Message posted by: Tressie Dalaya